Birthmark Doula Collective v. State of Louisiana

Reproductive healthcare providers and advocates challenge a state law that reclassifies mifepristone and misoprostol as controlled dangerous substances, arguing that the law unconstitutionally regulates and delays access to medications that people need for non-abortion reasons, often for emergencies such as postpartum hemorrhage, simply because those medications may also be used for an abortion. They allege the law violates the state constitution’s equal protection clause and single-subject and germane-amendment rules.